Thalidomide-Piperazine-PEG2-NH2 diTFA

发表于由

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白，专注于信号通路和疾病研究领域。

Thalidomide-Piperazine-PEG2-NH2 diTFA  纯度: 99.76%

Thalidomide-Piperazine-PEG2-NH2 diTFA 是一种合成的 E3 连接酶配体-linker 偶联物，包含基于 Thalidomide 的 cereblon 配体和 1 个 linker。

Thalidomide-Piperazine-PEG2-NH2 diTFA

Thalidomide-Piperazine-PEG2-NH2 diTFA Chemical Structure

规格 价格 是否有货 数量
25 mg ￥5600 In-stock
50 mg ￥8800 In-stock
100 mg ￥13200 In-stock
200 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

生物活性

Thalidomide-Piperazine-PEG2-NH2 diTFA is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and a linker used in PROTAC technology[1].

体外研究
(In Vitro)

PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins[2].

上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only.
分子量

701.57

Formula

C27H33F6N5O10
运输条件

Room temperature in continental US; may vary elsewhere.
储存方式

4°C, sealed storage, away from moisture

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
参考文献

  • [1]. Sato T, et al. Cereblon-Based Small-Molecule Compounds to Control Neural Stem Cell Proliferation in Regenerative Medicine. Front Cell Dev Biol. 2021;9:629326. Published 2021 Mar 11.

    [2]. Nalawansha DA, et al. PROTACs: An Emerging Therapeutic Modality in Precision Medicine. Cell Chem Biol. 2020;27(8):998-999.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务